Amaravati American Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 8.37 Cr
as on 12-07-2024
- Company Age 9 Year, 20 Days
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit -1032.28%
(FY 2020)
- Ebitda -1032.28%
(FY 2020)
- Net Worth -0.25%
(FY 2020)
- Total Assets 7.61%
(FY 2020)
About Amaravati American Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rao Chalasani and Chandrashekararao Mokkapati serve as directors at the Company.
- CIN/LLPIN
U74900AP2015PTC097890
- Company No.
097890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amaravati American Institute Of Medical Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekararao Mokkapati  | Director | 10-Dec-2015 | Current |
| Rao Chalasani | Director | 05-Feb-2020 | Current |
Financial Performance of Amaravati American Institute Of Medical Sciences.
Amaravati American Institute Of Medical Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1032.28% decrease in profit. The company's net worth dipped by a decrease of 0.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amaravati American Institute Of Medical Sciences?
In 2019, Amaravati American Institute Of Medical Sciences had a promoter holding of 0.12% and a public holding of 99.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Amaravati Global School Private LimitedActive 8 years 4 months
Chandrashekararao Mokkapati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amaravati American Institute Of Medical Sciences?
Unlock and access historical data on people associated with Amaravati American Institute Of Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amaravati American Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amaravati American Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
